Table 4.
Relationship Between Serum suPAR Levels of Patients With Cervical Cancer and Clinicopathological Features
| Feature | Cases | suPAR(ng/ml) | P‐value |
|---|---|---|---|
| TNM stage | |||
| I | 16 | 0.95 ± 0.08* | <0.05 |
| IIa | 40 | 2.09 ± 0.34 | |
| IIb | 12 | 2.89 ± 0.28 | |
| Lymph node metastasis | |||
| Yes | 24 | 3.26 ± 0.54 | <0.01 |
| No | 32 | 1.03 ± 0.23 | |
| Depth of infiltration | |||
| Myometrial invasion 2/3 | 26 | 3.02 ± 0.65 | <0.01 |
| Myometrial invasion <2/3 | 40 | 0.98 ± 0.32 | |
| Vessel thrombosis | |||
| Yes | 13 | 3.23 ± 1.23 | <0.01 |
| No | 43 | 1.86 ± 0.56 | |
| Pathological classification | |||
| Well differentiated | 12 | 1.98 ± 0.56 | >0.05 |
| Moderately differentiated | 23 | 2.23 ± 0.68 | |
| Poorly differentiated | 21 | 2.35 ± 0.54 |
*Compared with II‐IIb phase.